Form 4: Zura Bio Director Someit Sidhu Acquires Shares in Private Placement
SEC Form 4 Filing
Director Someit Sidhu reports acquisition of Zura Bio shares through a private placement and indirect holdings.
Summary
- On April 22, 2024, Someit Sidhu, a director of Zura Bio Ltd, acquired 1,186,901 Class A ordinary shares at a price of $3.13 per share through a private placement.
- These shares were acquired via Pegasus LLC, of which Sidhu is the sole member and beneficial owner.
- Sidhu also has indirect beneficial ownership of 351,000 Class A ordinary shares held by JATT Ventures, L.P., where he serves as the sole director of the general partner.
- Additionally, Sidhu directly owns 2,137,146 Class A ordinary shares.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting a transaction. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Key Dates
| Date | Description |
|---|---|
| 04/18/2024 | Date of the Securities Purchase Agreement between Zura Bio and Pegasus LLC |
| 04/22/2024 | Date of the transaction where shares were acquired |
| 04/24/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.